204 related articles for article (PubMed ID: 37084653)
1. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
[TBL] [Abstract][Full Text] [Related]
2. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
[TBL] [Abstract][Full Text] [Related]
4. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
[TBL] [Abstract][Full Text] [Related]
5. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Zerbini G; Lamacchia O; Nicolucci A; Pugliese G;
BMC Med; 2021 Mar; 19(1):66. PubMed ID: 33715620
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y;
Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease.
Garofolo M; Napoli V; Lucchesi D; Accogli S; Mazzeo ML; Rossi P; Neri E; Del Prato S; Penno G
Diabetes Metab Res Rev; 2023 Jan; 39(1):e3585. PubMed ID: 36273390
[TBL] [Abstract][Full Text] [Related]
9. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
Yamamoto Y; Hanai K; Mori T; Yokoyama Y; Yoshida N; Murata H; Shinozaki T; Babazono T
Diabetologia; 2022 Jan; 65(1):234-245. PubMed ID: 34739552
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Shi S; Ni L; Gao L; Wu X
Front Endocrinol (Lausanne); 2022; 13():871272. PubMed ID: 35721745
[TBL] [Abstract][Full Text] [Related]
11. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk.
Scilletta S; Di Marco M; Miano N; Filippello A; Di Mauro S; Scamporrino A; Musmeci M; Coppolino G; Di Giacomo Barbagallo F; Bosco G; Scicali R; Piro S; Purrello F; Di Pino A
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238622
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.
Ito H; Antoku S; Izutsu T; Kusano E; Matsumoto S; Yamasaki T; Mori T; Togane M
Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506
[TBL] [Abstract][Full Text] [Related]
13. Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
Agarwal R; Anker SD; Filippatos G; Pitt B; Rossing P; Ruilope LM; Boletis J; Toto R; Umpierrez GE; Wanner C; Wada T; Scott C; Joseph A; Ogbaa I; Roberts L; Scheerer MF; Bakris GL
Nephrol Dial Transplant; 2022 Jun; 37(7):1261-1269. PubMed ID: 34850173
[TBL] [Abstract][Full Text] [Related]
14. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
15. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
Huang B; Wen W; Ye S
Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha I; Matias P; Mateus S; Aguiar F; Pereira P; Perneta Santos M; Costa R; Lourenço A; Guia J; Barata JD; Campos L
Nefrologia; 2016; 36(5):503-509. PubMed ID: 27445098
[TBL] [Abstract][Full Text] [Related]
18. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic risk.
Di Bonito P; Mozzillo E; Rosanio FM; Maltoni G; Piona CA; Franceschi R; Ripoli C; Ricciardi MR; Tornese G; Arnaldi C; Iovane B; Iafusco D; Zanfardino A; Suprani T; Savastio S; Cherubini V; Tiberi V; Piccinno E; Schiaffini R; Delvecchio M; Casertano A; Maffeis C; Franzese A;
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2033-2041. PubMed ID: 34083127
[TBL] [Abstract][Full Text] [Related]
19. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.
Sasso FC; Pafundi PC; Gelso A; Bono V; Costagliola C; Marfella R; Sardu C; Rinaldi L; Galiero R; Acierno C; Caturano A; de Sio C; De Nicola L; Salvatore T; Nevola R; Adinolfi LE; Minutolo R;
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):923-930. PubMed ID: 31377186
[TBL] [Abstract][Full Text] [Related]
20. Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
Ruilope LM; Pitt B; Anker SD; Rossing P; Kovesdy CP; Pecoits-Filho R; Pergola P; Joseph A; Lage A; Mentenich N; Scheerer MF; Bakris GL
Nephrol Dial Transplant; 2023 Feb; 38(2):372-383. PubMed ID: 35451488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
